Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806700 · ClinicalTrials.gov registry record · NA
Twitter and Diabetes
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 628
- Enrollment target
NCT02806700: Completed NA study, sponsored by University of Pennsylvania.
NCT02806700 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 628 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02806700, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 628 participants
- Enrollment target
Study Summary
Twitter use is surprisingly well represented across broad demographic population segments and health-related messages. The promise of using Twitter is that its use is growing rapidly, it allows the investigators to view communications that were impossible to intercept before, and it potentially provides information faster and less expensively than collection from other media channels. Prior work also supports that social media interventions can improve health behavior change (e.g. weight loss, physical activity) and outcomes.The overarching goals of this proposal are to understand the uses and limitations of this communication channel to improve patients' ability to manage their CV health condition.
Interventions
- BEHAVIORAL Twitter Diabetes Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 628 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02806700
The ClinicalTrials.gov registry entry for NCT02806700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 628 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Twitter Diabetes Intervention is the first listed.
NCT02806700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02806700 about?
NCT02806700 is a clinical study titled "Twitter and Diabetes". Twitter use is surprisingly well represented across broad demographic population segments and health-related messages. The promise of using Twitter is that its use is growing rapidly, it allows the investigators to view communications that were impossible to intercept before, and it potentially prov...
What is the current status of trial NCT02806700?
This trial is currently completed. It is a NA study. The enrollment target is 628 participants. The study started on 2016-06. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02806700?
The interventions under investigation include: Twitter Diabetes Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02806700?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.